Browse Category

Stock Market News 9 January 2026

Applied Digital stock jumps again as AI data-center demand and hyperscaler talks drive the tape

Applied Digital stock jumps again as AI data-center demand and hyperscaler talks drive the tape

Applied Digital shares rose 18% to $37.68 in after-hours trading Friday after reporting fiscal Q2 revenue of $126.6 million, beating estimates. The company announced new leases totaling 600 MW, including a $5 billion, 200 MW deal at its Polaris Forge 2 campus. Cash stood at $1.91 billion as of Nov. 30, with $2.59 billion in long-term debt. Net loss for the quarter was $19.1 million.
AMD stock dips after hours as focus shifts from CES to the next catalysts

AMD stock dips after hours as focus shifts from CES to the next catalysts

AMD shares fell 0.7% to $203.17 in after-hours trading Friday, despite the PHLX semiconductor index hitting a record as the S&P 500 closed at an all-time high. The stock moved between $202.88 and $207.27 during the session, with about 24.1 million shares traded. Investors are awaiting AMD’s upcoming results and U.S. inflation data due January 13.
Palantir stock ticks higher after hours as jobs data cools and Feb. 2 earnings loom

Palantir stock ticks higher after hours as jobs data cools and Feb. 2 earnings loom

Palantir Technologies shares rose 0.3% to $177.49 in after-hours trading Friday, following a regular session with 31.2 million shares traded. The move came as U.S. payrolls rose by 50,000 in December, missing forecasts, while the jobless rate fell to 4.4%. Palantir remains below its 50-day moving average of $180.83 and well under its 52-week high of $207.52. The company’s next earnings report is expected Feb. 2.
Netflix stock slips after hours as Goldman trims target and Warner deal battle drags on

Netflix stock slips after hours as Goldman trims target and Warner deal battle drags on

Netflix shares fell 1.2% to $89.46 in after-hours trading Friday after Goldman Sachs cut its price target to $112 and maintained a Neutral rating. Warner Bros. Discovery’s board rejected Paramount’s revised bid and reaffirmed its $82.7 billion agreement with Netflix, while Paramount continues to push its $30-per-share cash offer. Investors await Netflix’s January 20 earnings and Paramount’s January 21 tender deadline.
9 January 2026
Alphabet (GOOG) stock ticks up after-hours as Google sets Feb. 4 earnings call, CEO sale disclosed

Alphabet (GOOG) stock ticks up after-hours as Google sets Feb. 4 earnings call, CEO sale disclosed

Alphabet Class C shares rose about 1% to $329.14 in after-hours trading Friday. CEO Sundar Pichai sold 32,500 Class C shares for roughly $10.4 million on Jan. 7, leaving him with over 2.2 million. The company reports quarterly results Feb. 4. EU regulators are expected to rule by Feb. 10 on Alphabet’s $32 billion Wiz acquisition.
Meta stock edges higher after nuclear power deals aimed at AI data centers

Meta stock edges higher after nuclear power deals aimed at AI data centers

Meta shares rose 1.1% to $653.06 in after-hours trading Friday after announcing nuclear power deals to supply its AI data centers. Agreements with Vistra, Oklo, and TerraPower could support up to 6.6 gigawatts of nuclear capacity by 2035. Financial terms were not disclosed. Investors are watching project timelines and permitting.
Amazon stock edges up after-hours as Amazon Pharmacy adds Novo’s Wegovy pill

Amazon stock edges up after-hours as Amazon Pharmacy adds Novo’s Wegovy pill

Amazon shares rose 0.4% after hours to $247.33 following news that Amazon Pharmacy will offer Novo Nordisk’s Wegovy weight-loss pill at $25 per month for insured customers and $149 for cash-pay. The pill, approved by the FDA in December, will be shipped to all 50 states. Investors await Amazon’s Q4 results on Feb. 5 and a key EU digital proposal on Jan. 20.
Apple stock snaps 7-session skid as Evercore lifts target; Apple Card switch looms

Apple stock snaps 7-session skid as Evercore lifts target; Apple Card switch looms

Apple shares rose 0.13% to $259.37 Friday, ending a seven-day losing streak. Evercore raised its price target to $330 and lifted quarterly estimates ahead of Apple’s Jan. 29 results. Apple and Chase set a roughly 24-month timeline to move the Apple Card portfolio from Goldman Sachs. CEO Tim Cook received $74.3 million in 2025 compensation, mostly in stock awards.
Polestar stock drops despite “best year ever” sales; Feb. 18 update is next test

Polestar stock drops despite “best year ever” sales; Feb. 18 update is next test

Polestar shares fell 5.9% to $20.90 in Friday’s Nasdaq session after the company reported preliminary 2025 retail sales of about 60,119 cars, up 34%, and a 27% rise in fourth-quarter volumes. The company said a December ADS ratio change restored compliance with Nasdaq’s $1 bid-price rule. CEO Michael Lohscheller set Feb. 18 for a strategy update. Europe now accounts for 78% of sales as U.S. tariffs and competition weigh.
Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill

Hims & Hers stock slides as Amazon starts selling Novo Nordisk’s new Wegovy pill

Hims & Hers shares dropped 5.3% to $32.06 after Amazon Pharmacy began offering Novo Nordisk’s Wegovy weight-loss pill. Bank of America cut its price target on Hims, citing margin and spending risks for 2026. The stock fell from an intraday high of $34.35. Investors are watching for signs of pricing pressure and updated forecasts ahead of Hims’ next earnings report.
Las Vegas Sands stock slides as Macau margin jitters flare — what investors are watching next

Las Vegas Sands stock slides as Macau margin jitters flare — what investors are watching next

Las Vegas Sands shares fell 4.3% to $59.25 Friday afternoon, underperforming a rising U.S. market. Analysts cited concerns over Macau operating costs and fourth-quarter margins after Sands China and Melco Resorts dropped sharply in Hong Kong. Other casino stocks with Macau exposure also declined. Investors are watching for the company’s next results update later this month.
9 January 2026
Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

Arcutis stock sinks 5% after wild swing as traders eye Fed, FDA clock and earnings

Arcutis Biotherapeutics shares fell 5.3% to $28.29 Friday after an early surge, tracking a shift in rate expectations following a soft U.S. jobs report. Broader biotech indexes rose. Investors are watching for Arcutis’ next earnings on Feb. 24 and an FDA decision on ZORYVE for children by June 29. The Fed’s late-January meeting remains a key focus for traders.

Stock Market Today

Oil stocks jump on Iran risk lift for crude — what to watch before Monday

Oil stocks jump on Iran risk lift for crude — what to watch before Monday

7 February 2026
U.S. oil stocks surged Friday as crude prices rose on renewed Middle East tensions. Exxon Mobil gained 2.0%, ConocoPhillips 2.5%, and Occidental Petroleum 2.7%. Refiners rallied after a national union deal eased strike risk, though BP’s Whiting plant faces a local dispute. Brent settled at $68.05 a barrel, up 0.74%.
Silver price rebound masks fresh stress after CME lifts margins again

Silver price rebound masks fresh stress after CME lifts margins again

7 February 2026
Spot silver surged 8.6% to $77.33 an ounce Friday after dropping below $65, but still lost over 8.7% for the week. CME Group raised margin requirements for COMEX silver futures to 18% from 15%, effective after Feb. 6. China’s UBS SDIC Silver Futures Fund hit its 10% down limit for a fifth session. Traders await key U.S. jobs and inflation data next week.
Gold price near $5,000: China keeps buying as CME margin hikes raise the stakes

Gold price near $5,000: China keeps buying as CME margin hikes raise the stakes

7 February 2026
China’s central bank raised gold reserves for a 15th month in January, reaching 74.19 million ounces worth $369.58 billion. Gold prices swung sharply, hitting a record near $5,600 before dropping to $4,403.24. CME Group hiked COMEX gold futures margins to 9% after recent volatility. U.S. jobs and inflation data are due next week after a delay.
Go toTop